|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tachimori Y, Ozawa S, Numasaki H,
Fujishiro M, Matsubara H, Oyama T, Shinoda M, Toh Y, Udagawa H and
Uno T: Comprehensive registry of esophageal cancer in Japan, 2007.
Esophagus. 12:101–129. 2015. View Article : Google Scholar
|
|
3
|
Osugi H, Takemura M, Higashino M, Takada
N, Lee S, Ueno M, Tanaka Y, Fukuhara K, Hashimoto Y, Fujiwara Y, et
al: Causes of death and pattern of recurrence after esophagectomy
and extended lymphadenectomy for squamous cell carcinoma of the
thoracic esophagus. Oncol Rep. 10:81–87. 2003.
|
|
4
|
Ando N, Ozawa S, Kitagawa Y, Shinozawa Y
and Kitajima M: Improvement in the results of surgical treatment of
advanced squamous esophageal carcinoma during 15 consecutive years.
Ann Surg. 232:225–232. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sofia Vala I, Martins LR, Imaizumi N,
Nunes RJ, Rino J, Kuonen F, Carvalho LM, Rüegg C, Grillo IM, Barata
JT, et al: Low doses of ionizing radiation promote tumor growth and
metastasis by enhancing angiogenesis. PLoS One. 5:e112222010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Park JK, Jang SJ, Kang SW, Park S, Hwang
SG, Kim WJ, Kang JH and Um HD: Establishment of animal model for
the analysis of cancer cell metastasis during radiotherapy. Radiat
Oncol. 7:1532012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Moncharmont C, Levy A, Guy JB, Falk AT,
Guilbert M, Trone JC, Alphonse G, Gilormini M, Ardail D, Toillon
RA, et al: Radiation-enhanced cell migration/invasion process: A
review. Crit Rev Oncol Hematol. 92:133–142. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haslehurst AM, Koti M, Dharsee M, Nuin P,
Evans K, Geraci J, Childs T, Chen J, Li J, Weberpals J, et al: EMT
transcription factors snail and slug directly contribute to
cisplatin resistance in ovarian cancer. BMC Cancer. 12:912012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wintzell M, Löfstedt L, Johansson J,
Pedersen AB, Fuxe J and Shoshan M: Repeated cisplatin treatment can
lead to a multiresistant tumor cell population with stem cell
features and sensitivity to 3-bromopyruvate. Cancer Biol Ther.
13:1454–1462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee JM, Dedhar S, Kalluri R and Thompson
EW: The epithelial-mesenchymal transition: New insights in
signaling, development, and disease. J Cell Biol. 172:973–981.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lee MY and Shen MR: Epithelial-mesenchymal
transition in cervical carcinoma. Am J Transl Res. 4:1–13.
2012.PubMed/NCBI
|
|
12
|
Barcellos-Hoff MH and Akhurst RJ:
Transforming growth factor-beta in breast cancer: Too much, too
late. Breast Cancer Res. 11:2022009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Morrison CD, Parvani JG and Schiemann WP:
The relevance of the TGF-β Paradox to EMT-MET programs. Cancer
Lett. 341:30–40. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nagaraj NS and Datta PK: Targeting the
transforming growth factor-beta signaling pathway in human cancer.
Expert Opin Investig Drugs. 19:77–91. 2010. View Article : Google Scholar
|
|
15
|
Wang M, Hada M, Saha J, Sridharan DM,
Pluth JM and Cucinotta FA: Protons sensitize epithelial cells to
mesenchymal transition. PLoS One. 7:e412492012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu MA, Kiang A, Wang-Rodriguez J, Rahimy
E, Haas M, Yu V, Ellies LG, Chen J, Fan JB, Brumund KT, et al:
Nicotine promotes acquisition of stem cell and
epithelial-to-mesenchymal properties in head and neck squamous cell
carcinoma. PLoS One. 7:e519672012. View Article : Google Scholar
|
|
17
|
Biswas S, Guix M, Rinehart C, Dugger TC,
Chytil A, Moses HL, Freeman ML and Arteaga CL: Inhibition of
TGF-beta with neutralizing antibodies prevents radiation-induced
acceleration of metastatic cancer progression. J Clin Invest.
117:1305–1313. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Tsukamoto H, Shibata K, Kajiyama H,
Terauchi M, Nawa A and Kikkawa F: Irradiation-induced
epithelial-mesenchymal transition (EMT) related to invasive
potential in endometrial carcinoma cells. Gynecol Oncol.
107:500–504. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He E, Pan F, Li G and Li J: Fractionated
ionizing radiation promotes epithelial-mesenchymal transition in
human esophageal cancer cells through PTEN deficiency-mediated Akt
activation. PLoS One. 10:e01261492015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ocker M: Deacetylase inhibitors - focus on
non-histone targets and effects. World J Biol Chem. 1:55–61. 2010.
View Article : Google Scholar
|
|
21
|
Singh TR, Shankar S and Srivastava RK:
HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL
in breast carcinoma. Oncogene. 24:4609–4623. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shankar S, Davis R, Singh KP, Kurzrock R,
Ross DD and Srivastava RK: Suberoylanilide hydroxamic acid
(Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells
ortho-topically implanted in BALB/c nude mice. Mol Cancer Ther.
8:1596–1605. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Marks PA and Xu WS: Histone deacetylase
inhibitors: Potential in cancer therapy. J Cell Biochem.
107:600–608. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Duenas-Gonzalez A, Candelaria M,
Perez-Plascencia C, Perez-Cardenas E, de la Cruz-Hernandez E and
Herrera LA: Valproic acid as epigenetic cancer drug: Preclinical,
clinical and transcriptional effects on solid tumors. Cancer Treat
Rev. 34:206–222. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Atmaca A, Al-Batran SE, Maurer A, Neumann
A, Heinzel T, Hentsch B, Schwarz SE, Hövelmann S, Göttlicher M,
Knuth A, et al: Valproic acid (VPA) in patients with refractory
advanced cancer: A dose escalating phase I clinical trial. Br J
Cancer. 97:177–182. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mohammed TA, Holen KD, Jaskula-Sztul R,
Mulkerin D, Lubner SJ, Schelman WR, Eickhoff J, Chen H and Loconte
NK: A pilot phase II study of valproic acid for treatment of
low-grade neuroendocrine carcinoma. Oncologist. 16:835–843. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shoji M, Ninomiya I, Makino I, Kinoshita
J, Nakamura K, Oyama K, Nakagawara H, Fujita H, Tajima H, Takamura
H, et al: Valproic acid, a histone deacetylase inhibitor, enhances
radiosensitivity in esophageal squamous cell carcinoma. Int J
Oncol. 40:2140–2146. 2012.PubMed/NCBI
|
|
28
|
Makita N, Ninomiya I, Tsukada T, Okamoto
K, Harada S, Nakanuma S, Sakai S, Makino I, Kinoshita J, Hayashi H,
et al: Inhibitory effects of valproic acid in DNA double-strand
break repair after irradiation in esophageal squamous carcinoma
cells. Oncol Rep. 34:1185–1192. 2015.PubMed/NCBI
|
|
29
|
Watanabe T, Tajima H, Hironori H,
Nakagawara H, Ohnishi I, Takamura H, Ninomiya I, Kitagawa H,
Fushida S, Tani T, et al: Sodium valproate blocks the transforming
growth factor (TGF)-β1 autocrine loop and attenuates the
TGF-β1-induced collagen synthesis in a human hepatic stellate cell
line. Int J Mol Med. 28:919–925. 2011.PubMed/NCBI
|
|
30
|
Ruscetti M, Dadashian EL, Guo W, Quach B,
Mulholland DJ, Park JW, Tran LM, Kobayashi N, Bianchi-Frias D, Xing
Y, et al: HDAC inhibition impedes epithelial-mesenchymal plasticity
and suppresses metastatic, castration-resistant prostate cancer.
Oncogene. 35:3781–3795. 2016. View Article : Google Scholar :
|
|
31
|
Sakamoto T, Kobayashi S, Yamada D, Nagano
H, Tomokuni A, Tomimaru Y, Noda T, Gotoh K, Asaoka T, Wada H, et
al: A Histone deacetylase inhibitor suppresses
epithelial-mesenchymal transition and attenuates chemoresistance in
biliary tract cancer. PLoS One. 11:e01459852016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Paoli P, Giannoni E and Chiarugi P:
Anoikis molecular pathways and its role in cancer progression.
Biochim Biophys Acta. 1833.3481–3498. 2013.
|
|
34
|
Radisky ES and Radisky DC: Matrix
metalloproteinase-induced epithelial-mesenchymal transition in
breast cancer. J Mammary Gland Biol Neoplasia. 15:201–212. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Schatton T and Frank MH: Cancer stem cells
and human malignant melanoma. Pigment Cell Melanoma Res. 21:39–55.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Castellanos JA, Merchant NB and
Nagathihalli NS: Emerging targets in pancreatic cancer:
Epithelial-mesenchymal transition and cancer stem cells. Onco
Targets Ther. 6:1261–1267. 2013.PubMed/NCBI
|
|
37
|
Lei W, Zhang K, Pan X, Hu Y, Wang D, Yuan
X, Shu G and Song J: Histone deacetylase 1 is required for
transforming growth factor-beta1-induced epithelial-mesenchymal
transition. Int J Biochem Cell Biol. 42:1489–1497. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bruzzese F, Leone A, Rocco M, Carbone C,
Piro G, Caraglia M, Di Gennaro E and Budillon A: HDAC inhibitor
vorinostat enhances the antitumor effect of gefitinib in squamous
cell carcinoma of head and neck by modulating ErbB receptor
expression and reverting EMT. J Cell Physiol. 226:2378–2390. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mateen S, Raina K, Agarwal C, Chan D and
Agarwal R: Silibinin synergizes with histone deacetylase and DNA
methyltransferase inhibitors in upregulating E-cadherin expression
together with inhibition of migration and invasion of human
non-small cell lung cancer cells. J Pharmacol Exp Ther.
345:206–214. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Feng J, Cen J, Li J, Zhao R, Zhu C, Wang
Z, Xie J and Tang W: Histone deacetylase inhibitor valproic acid
(VPA) promotes the epithelial mesenchymal transition of colorectal
cancer cells via up regulation of Snail. Cell Adhes Migr.
9:495–501. 2015. View Article : Google Scholar
|
|
41
|
Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee
SJ, Kim DS and Park SM: HDAC inhibitors induce
epithelial-mesenchymal transition in colon carcinoma cells. Oncol
Rep. 33:2299–2308. 2015.PubMed/NCBI
|
|
42
|
Kovacic JC, Mercader N, Torres M, Boehm M
and Fuster V: Epithelial-to-mesenchymal and
endothelial-to-mesenchymal transition: From cardiovascular
development to disease. Circulation. 125:1795–1808. 2012.
View Article : Google Scholar : PubMed/NCBI
|
